UBS Group’s Seagen Inc. Common Stock SGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-906,700
Closed -$192M 10345
2023
Q3
$192M Buy
906,700
+692,500
+323% +$138M 0.07% 297
2023
Q2
$41.2M Buy
+214,200
New +$42.6M 0.01% 940
2022
Q4
Sell
-10,000
Closed -$1.37M 11399
2022
Q3
$1.37M Hold
10,000
﹤0.01% 3478
2022
Q2
$1.77M Buy
+10,000
New +$1.44M ﹤0.01% 3257
2019
Q4
Sell
-12,200
Closed -$1.04M 8510
2019
Q3
$1.04M Buy
+12,200
New +$894K ﹤0.01% 3937
2016
Q1
Sell
-1,000
Closed -$45K 8332
2015
Q4
$45K Hold
1,000
﹤0.01% 5915
2015
Q3
$39K Hold
1,000
﹤0.01% 6048
2015
Q2
$48K Hold
1,000
﹤0.01% 6045
2015
Q1
$35K Sell
1,000
-300
-23% -$10.2K ﹤0.01% 6398
2014
Q4
$42K Buy
+1,300
New +$45.3K ﹤0.01% 6709

Other funds holding SGEN

UBS Group's SGEN Position: Q4 2023 in Review

UBS Group sold out of Seagen Inc. Common Stock (SGEN) in Q4 2023, closing a stake of 64,453 shares — an estimated $13.7M sold.

UBS Group first reported a position in SGEN in Q4 2014 and held it in 36 quarters. The position peaked at $29.5M in Q4 2021. 6 funds tracked by Wall St. Rank hold SGEN as of Q4 2023.

  • UBS Group reported no remaining Seagen Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • UBS Group sold 64,453 Seagen Inc. Common Stock shares in Q4 2023, an estimated $13.7M.
  • UBS Group first reported a position in Seagen Inc. Common Stock in Q4 2014 and held it in 36 quarters.
  • UBS Group's Seagen Inc. Common Stock position peaked at $29.5M in Q4 2021.
  • 6 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q4 2023.

Based on UBS Group's 13F filing for Q4 2023, filed 9 Feb 2024.